These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 25661357)
1. A novel anti-VEGF165 monoclonal antibody-conjugated liposomal nanocarrier system: physical characterization and cellular uptake evaluation in vitro and in vivo. Shi C; Gao F; Gao X; Liu Y Biomed Pharmacother; 2015 Feb; 69():191-200. PubMed ID: 25661357 [TBL] [Abstract][Full Text] [Related]
2. Novel drug delivery liposomes targeted with a fully human anti-VEGF165 monoclonal antibody show superior antitumor efficacy in vivo. Shi C; Cao H; He W; Gao F; Liu Y; Yin L Biomed Pharmacother; 2015 Jul; 73():48-57. PubMed ID: 26211582 [TBL] [Abstract][Full Text] [Related]
3. Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes. Xiang Y; Liang L; Wang X; Wang J; Zhang X; Zhang Q J Control Release; 2011 Jun; 152(3):402-10. PubMed ID: 21435361 [TBL] [Abstract][Full Text] [Related]
4. Smart IR780 Theranostic Nanocarrier for Tumor-Specific Therapy: Hyperthermia-Mediated Bubble-Generating and Folate-Targeted Liposomes. Guo F; Yu M; Wang J; Tan F; Li N ACS Appl Mater Interfaces; 2015 Sep; 7(37):20556-67. PubMed ID: 26322900 [TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768 [TBL] [Abstract][Full Text] [Related]
6. Transferrin coupled vesicular system for intracellular drug delivery for the treatment of cancer: development and characterization. Vaidya B; Vyas SP J Drug Target; 2012 May; 20(4):372-80. PubMed ID: 22339366 [TBL] [Abstract][Full Text] [Related]
7. Conjugation of bevacizumab to cationic liposomes enhances their tumor-targeting potential. Kuesters GM; Campbell RB Nanomedicine (Lond); 2010 Feb; 5(2):181-92. PubMed ID: 20148631 [TBL] [Abstract][Full Text] [Related]
8. LyP-1-conjugated PEGylated liposomes: a carrier system for targeted therapy of lymphatic metastatic tumor. Yan Z; Wang F; Wen Z; Zhan C; Feng L; Liu Y; Wei X; Xie C; Lu W J Control Release; 2012 Jan; 157(1):118-25. PubMed ID: 21827801 [TBL] [Abstract][Full Text] [Related]
9. A pH-responsive α-helical cell penetrating peptide-mediated liposomal delivery system. Zhang Q; Tang J; Fu L; Ran R; Liu Y; Yuan M; He Q Biomaterials; 2013 Oct; 34(32):7980-93. PubMed ID: 23891517 [TBL] [Abstract][Full Text] [Related]
10. The liposomal daunorubicin plus tamoxifen: improving the stability, uptake, and biodistribution of carriers. Shao M; Sun SL; Li MH; Li BX; Yu H; Shen ZY; Ren YC; Hao ZF; Chang ND; Peng HS; Yang BF J Liposome Res; 2012 Jun; 22(2):168-76. PubMed ID: 22428938 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery. Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740 [TBL] [Abstract][Full Text] [Related]
12. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391 [TBL] [Abstract][Full Text] [Related]
13. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo. Baek SE; Lee KH; Park YS; Oh DK; Oh S; Kim KS; Kim DE J Control Release; 2014 Dec; 196():234-42. PubMed ID: 25450401 [TBL] [Abstract][Full Text] [Related]
14. Efficient VEGF targeting delivery of DOX using Bevacizumab conjugated SiO Zhu R; Wang Z; Liang P; He X; Zhuang X; Huang R; Wang M; Wang Q; Qian Y; Wang S Acta Biomater; 2017 Nov; 63():163-180. PubMed ID: 28923539 [TBL] [Abstract][Full Text] [Related]
15. Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells. Wang Y; Zhou J; Qiu L; Wang X; Chen L; Liu T; Di W Biomaterials; 2014 May; 35(14):4297-309. PubMed ID: 24565522 [TBL] [Abstract][Full Text] [Related]
16. Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. Goren D; Horowitz AT; Zalipsky S; Woodle MC; Yarden Y; Gabizon A Br J Cancer; 1996 Dec; 74(11):1749-56. PubMed ID: 8956788 [TBL] [Abstract][Full Text] [Related]
17. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo. He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713 [TBL] [Abstract][Full Text] [Related]
18. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104 [TBL] [Abstract][Full Text] [Related]
19. Multifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicity. Koren E; Apte A; Jani A; Torchilin VP J Control Release; 2012 Jun; 160(2):264-73. PubMed ID: 22182771 [TBL] [Abstract][Full Text] [Related]
20. RGD conjugated liposome-hollow silica hybrid nanovehicles for targeted and controlled delivery of arsenic trioxide against hepatic carcinoma. Fei W; Zhang Y; Han S; Tao J; Zheng H; Wei Y; Zhu J; Li F; Wang X Int J Pharm; 2017 Mar; 519(1-2):250-262. PubMed ID: 28109899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]